n.a. (ZMH)

0.00
NYSE
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NYSE
Shares Outstanding 170.40M
Div & Yield N.A. (N.A)

Health Stocks in Motion

Matria Healthcare rises after agreeing to buy disease management company CorSolutions.

Toll Brothers Looks Ready to Buy

The homebuilder's chart says it's time to step in. Plus the Nasdaq, Oracle and more.

Market Has Spirit, Just Not Enough

Despite underlying buying power, the Dow probably can't punch through resistance here.

Unhealthy Spec in Health Care

Unhealthy Spec in Health Care

These stocks seem cheap, but with no catalyst and poor fundamentals, they're best avoided.

Health Stocks in Motion

Inspire Pharmaceuticals' dry-eye treatment fails to inspire FDA approval.

Unhealthy Spec in Health Care

These stocks seem cheap, but with no catalyst and poor fundamentals, they're best avoided.

Zimmer in Dental Education Partnership

The orthopedic implant company says the six-year pact covers implant dentistry as well.

Cramer's 'Mad Money' Recap: The Latin Beat

Cramer sees a rally in Argentina and Brazil spurred by President Bush's visit. Also, subpoenas.

Price Pinch Zaps Zimmer

Hospital belt-tightening talk strangles a once-hot stock.

Zimmer Forecast Steadies Ship

The stock has dropped sharply in the last month, but a solid report pushes shares higher late.

Cramer's 'Mad Money Lightning Round': Shine On, Syneron

Cramer's 'Mad Money Lightning Round': Shine On, Syneron

It's got a good cellulite buster.

Cramer's 'Mad Money' Recap: Latin Lessons

Cramer's 'Mad Money' Recap: Latin Lessons

Cramer calls Peru a 'capitalist paradise' and names some up-and-coming stocks.

Coming Week: Earnings and Storm

Profit data continue to roll in, but investors also will keep a close eye on Hurricane Wilma.

We Won't Repeat 1987 Here

Stop fearing the worst; we've already seen it for this go-round.

Price Is Wrong at Stryker

Orthopedic-device makers such as Stryker, Zimmer and Biomet have been hit as they lose leverage.

We Won't Repeat 1987 Here

Stop fearing the worst; we've already seen it for this go-round.

Stryker Quarter Disappoints

The stock slips after third-quarter numbers fail to match estimates.

Cramer's 'Mad Money Lightning Round': Sorry, Bebe

You're not one of Cramer's high-end retail plays.

Biomet, Zimmer Clash on Pricing Picture

Biomet, Zimmer Clash on Pricing Picture

Some investors are wondering if hospital belt-tightening is about to pinch Biomet's growth.

Cramer's 'Mad Money Lightning Round': Sip Some Starbucks

They got the same-store juice, Cramer observes.

Cramer's 'Mad Money' Recap: Crowning Cell-Phone Play

Cramer says video over cell phones is the way to go. That's why he likes Crown Castle.

Wright Medical Doesn't Have the Right Answer

The stock licks its wounds after a profit shortfall and CEO departure stoke a 20% drop.

Competition Limps Toward Knee Implant Market

Competition Limps Toward Knee Implant Market

J&J continues to control a lucrative niche, but rivals like Zimmer are making their move.

Biomet Shoots From the Hip

The implant maker's earnings surge, driven by strength in hip sales. But knees look wobbly.

Price Pressure Pricks Zimmer

The stock gives ground as investors consider a possible sales slowdown.

It's Not Time to Buy Zimmer Yet

To sell the stock now is to bet that everything will go wrong, which is unlikely. But it's not yet time to go long.

'RealMoney' Radio Recap: High on Energy

The sector's facing some headwinds right now, but it's far too important not to own a bunch.

Discount Talk Zaps Zimmer

The stock pulls back from a recent high as investors wonder about possible pricing pressure.

Cramer's 'Mad Money' Recap: A Baby Boomer Portfolio

Cramer recommends stocks in laser surgery, assisted living, insurance and other sectors.

'Real Money' Radio Recap: Raising Your Risk Tolerance

'Real Money' Radio Recap: Raising Your Risk Tolerance

With oil up, some long-shot energy names could start working.